CD19 MicroBeads, mouse

CD19 MicroBeads, mouse

CD19 MicroBeads were developed for the positive selection or depletion of mouse B cells from peripheral blood and various tissues such as bone marrow, lymph nodes, and spleen.

Background information

CD19 is expressed on B lineage cells throughout their development from the early pro-B cell stages onwards and is down-regulated upon terminal differentiation to plasma cells.

Downstream applications

B cells isolated with CD19 MicroBeads were used to study the accessibility of enhancer elements during B cell development by
in vivo
Cell extracts prepared from purified B cells were used to analyze conditions for V(D)J recombination in a cell-free system.
Furthermore, mRNA was isolated from selected B cells for microarray analyses to quantify transcription factor expression during B cell development.


For positive selection: MS, LS, XS, or autoMACS
Columns. For depletion: LD, D, or autoMACS Columns.
  • Selected references

    1. Shaffer, A. L. et al. (1997)
      In vivo
      occupancy of the kappa light chain enhancers in primary pro- and pre-B cells: a model for kappa locus activation.
      Immunity 6: 131-143
    2. Stanhope-Baker et al. (1996) Cell-type-specific regulation of distinct sets of gene targets by Pax3 and Pax3/FKHR. Cell 85: 887-897
    3. Portis, T. and Longnecker, R. (2003) Epstein-Barr virus LMP2A interferes with global transcription factor regulation when expressed during B-lymphocyte development. J. Virol. 77: 105-114
Product options: 1
for 2×
total cells
USD 675.00